Advanced search

Find pages with...
Then narrow your results by...

About 53 search results

Dozens of health products seized from Aphrodite Aesthetic Clinic in North York, Ontario, may pose serious health risks

https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2019/70749a-eng.php

Aug 26, 2019 ... liver injury, gallstones, kidney stones and kidney damage. It should not be used by patients with chronic malabsorption, gallbladder problems or by those who are allergic to orlistat. It should be used with caution in patients taking cyclosporine, diabetic or thyroid medication, and those with bowel disease or kidney damage. Because it affects absorption from

Endo Surgical Pack System (2019-07-23)

https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2019/70715r-eng.php

Aug 16, 2019 ...Endo Surgical Pack System (2019-07-23) Report a Concern Starting date: July 23, 2019 Posting date: August 16, 2019 Type of communication: Medical Device Recall Subcategory: Medical Device Hazard classification: Type III Source of recall: Health Canada Issue: Medical Devices Audience: General Public, Healthcare Professionals, Hospitals Identification number

Multiple unauthorized eye solutions and an acne gel sold at two stores in the Lower Mainland of BC may pose serious health risks

https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2019/69608a-eng.php

Apr 15, 2019 ... and improve their health or they may contain ingredients that could interact with other medications and foods. For all of these reasons, unauthorized health products could cause serious health effects. Selling unauthorized health products in Canada is illegal. Some of the unauthorized health products are packaged and labelled in Japanese characters. As a result

Barbed Sutures and the Potential Risk of Small Bowel Obstruction

https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2018/66930a-eng.php

Aug 10, 2018 ...Barbed Sutures and the Potential Risk of Small Bowel Obstruction Report a Concern Starting date: May 31, 2018 Posting date: May 31, 2018 Type of communication: Dear Healthcare Professional Letter Subcategory: Medical Device Source of recall: Health Canada Issue: Medical Devices, New safety information Audience: Healthcare Professionals, Hospitals

Metoclopramide - Abnormal Involuntary Movements (Extrapyramidal Symptoms) in Children - For the Public

https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2015/43171a-eng.php

Aug 9, 2018 ... information concerning the potential risk of abnormal involuntary movements of the body called extrapyramidal symptoms that have been reported in children treated with metoclopramide at a recommended dose. In Canada, metoclopramide is approved for the treatment of delayed stomach emptying and for medical procedures such as inserting a tube into the small bowel (called

Metoclopramide - Abnormal Involuntary Movements (Extrapyramidal Symptoms) in Children - For Health Professionals

https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2015/43167a-eng.php

Aug 9, 2018 ... Canada, would like to inform you of important new safety information regarding the risk of extrapyramidal symptoms in children taking the daily recommended dose of metoclopramide (0.5 mg/kg/day). Metoclopramide is approved in Canada for the treatment of delayed gastric emptying and small bowel intubation. Extrapyramidal symptoms may occur in children receiving

Important safety information on Fleet Phospho-Soda (sodium phosphates oral solution) with kidney impairment and nephrocalcinosis - For Health Professionals - MERCK Consumer Pharmaceuticals

https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2005/14361a-eng.php

Feb 6, 2013 ... significant impairment of renal function. Use with caution in patients with pre-existing electrolyte disturbances, patients taking drugs that may affect electrolyte levels, the elderly or in debilitated patients. Adequate hydration is very important to safely and effectively use sodium phosphates as a bowel cleanser. Medications such as diuretics may exacerbate volume

Important safety information on pms-Sodium Phosphates Oral Solution with kidney impairment and nephrocalcinosis - For Health Professionals - Pharmascience Inc.

https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2005/14360a-eng.php

Feb 6, 2013 .... Adequate hydration is very important to safely and effectively use sodium phosphates as a bowel cleanser. Medications such as diuretics may exacerbate volume depletion associated with bowel cleansing. Pharmascience Inc. has until this date not received any spontaneous reports of renal failure associated with the use of Sodium Phosphates Oral Solution

Hospital Beds - Risk of Patient Entrapment

https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2017/62960a-eng.php

Aug 10, 2018 ...Hospital Beds - Risk of Patient Entrapment Report a Concern Starting date: April 7, 2017 Posting date: April 10, 2017 Type of communication: Dear Healthcare Professional Letter Subcategory: Medical Device Source of recall: Health Canada Issue: Important Safety Information Audience: Healthcare Professionals, General Public Identification number: RA-62960

Oral sodium phosphate products are no longer authorized for purgative use - For Health Professionals

https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2009/14562a-eng.php

Mar 18, 2013 ... are regulated as natural health products. These products have actions as a laxative and a purgative, and have been used for the relief of constipation and for preparing the bowel for medical and surgical procedures. Phosphates Solution by Pharmascience Inc. (NPN 02230399) and Phoslax by Odan Laboratories Ltd. (NPN 80000689) were formerly authorized for both laxative

Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: